Prognostic significance of vascular endothelial growth factor expression in human ovarian carcinoma

British Journal of Cancer

Volumn 83, Issue 2, 2000, Pages 196-203

  Shen, G H ^a   Ghazizadeh, M ^a   Kawanami, O ^a   Shimizu, H ^a   Jin, E ^a   Araki, T ^a   Sugisaki, Y ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

Angiogenesis; Disease stage; Microvessel density; Ovarian tumours; Prognosis; Vascular endothelial growth factor

Indexed keywords

MESSENGER RNA; VASCULOTROPIN;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER STAGING; CANCER SURVIVAL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MICROVASCULATURE; OVARY CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TREATMENT OUTCOME;

EID: 0034046917     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjoc.2000.1228     Document Type: Article

References (35)

1. Abu-Jawdeh GM, Faix JD, Niloff J, Tognazzi K, Manseau E and Dvorak HF et al (1996) Strong expression of vascular permeability factor (vascular endothelial growth factor) and its receptor in ovarian borderline and malignant neoplasms. Lab Invest 74: 1105-1115
2. Boocock CA, Charnock-Jones DS, Sharkey AM, McLaren J, Barker PJ and Wright KA et al (1995) Expression of vascular endothelial growth factor and its receptor fit and KDR in ovarian carcinoma. J Natl Cancer Inst 87: 506-516
3. de Vries C, Escobedo JA, Ueno H, Houck K, Ferrara N and Williams LT (1992) The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science 255: 989-991
4. Ferrara N and Hanzel WJ (1989) Pituitary folicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun 161: 851-858
5. Ferrara N (1995) The role of vascular endothelial growth factor in pathological angiogenesis. Breast Cancer Res Treat 36: 121-137
6. Ferrara N (1999) Vascular endothelial growth factor: molecular and biological aspects. Curr Top Microbiol Immunol 237: 1-30
7. Folkman J (1986) How is blood vessel growth regulated in normal and neoplastic tissue? G.H.A. Clowes Memorial Award Lecture. Cancer Res 46: 467-473
8. Folkman J (1990) What is the evidence that tumours are angiogenesis-dependent? J Natl Cancer Inst 82: 4-6
9. Fujimoto J, Sakaguchi H, Hirose R, Ichigo S and Tamaya T (1998) Biologic implications of the expression of vascular endothelial growth factor subtypes in ovarian carcinoma. Cancer 83: 2528-2533
10. Garzetti GG, Ciavattini A, Lucarini G, Pugnaloni A, De Nictolis M and Amati S et al (1999a) Expression of vascular endothelial growth factor related to 72-kilodalton metalloproteinase immunostaining in patients with serous ovarian tumours. Cancer 85: 2219-2225
11. Garzetti GG, Ciavattini A, Lucarini G, Pugnaloni A, De Nictolis M and Amati S et al. (1999b) Vascular endothelial growth factor expression as a prognostic index in serous ovarian cystadenocarcinomas: relationship with MIBI immunostaining. Gynecol Oncol 73: 396-401
12. Ghazizadeh M, Ogawa H, Sasaki Y, Araki T and Aihara K (1997) Mucin carbohydrate antigens (T, Tn, and sialyl-Tn) in human ovarian carcinoma: Relationship with histopathology and prognosis. Hum Pathol 28: 960-966
13. Hartenbach EM, Olson TA, Goswitz JJ, Mohanraj D, Twiggs LB, Carson LF and Ramakrishnan S (1997) Vascular endothelial growth factor (VEGF) expression and survival in human epithelial ovarian carcinomas. Cancer Lett 121: 169-175
14. Hazelton D, Nicosia RF and Nicosia SV (1999) Vascular endothelial growth factor levels in ovarian cyst fluid correlate with malignancy. Clin Cancer Res 5: 823-829
15. Hollingsworth HC, Kohn EC, Steinberg SM, Rothenberg ML and Merino MJ (1995) Tumour angiogenesis in advanced stage ovarian carcinoma. Am J Pathol 147: 33-41
16. Kamat BR, Brown LF, Manseau EJ, Senger DR and Dvorak HF (1995) Expression of vascular permeability factor/vascular endothelial growth factor by human granulosa and theca lutein. Am J Pathol 146: 157-165
17. Keck PJ, Hauser SD, Krivi G, Sanzo K, Warren T and Feder J, et al (1989) Vascular permeability factor: an endothelial cell mitogen related to PDGF. Science 246: 1309-1312
18. Kim KJ, Li B, Winer J, Armanini M, Gillet N, Phillips HS and Ferrara N (1993) Inhibition of vascular endothelial growth factor induced angiogenesis suppresses tumor growth in vivo. Nature 362: 841-844
19. Kraft A, Weindel K, Oehs A, Marth C, Zmija J, Schumacher P et al. (1999) Vascular endothelial growth factor in sera and effusions of patients with malignant and nonmalignant disease. Cancer 85: 178-187
20. Millaure B, Shawver LK, Plate KH, Risau W and Ullrich A (1994) Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant. Nature 367: 576-579
21. Nakanishi Y, Kodama J, Yoshinouchi M, Tokumo K, Kamimura S, Okuda H and Kudo T (1997) The expression of vascular endothelial growth factor and transforming growth facotor-beta associates with angiogenesis in epithelial ovarian cancer. Int J Gynecol Pathol 16: 256-262
22. Olson TA, Mohanaraj D, Carson LF and Ramakrishnan S (1994) Vascular permeability factor gene expression in normal and neoplastic human ovaries. Cancer Res 54: 276-280
23. Orre M, Lotfi-Miri M, Mamers P and Rogers PAW (1998) Increased microvessel density in mucinous compared with malignant serous and benign tumours of the ovary. Br J Cancer 77: 2204-2209
24. Orre M and Rogers P (1999) VEGF, VEDFR-1, VEGFR-2, mivcrovessel density and endothelial cell proliferation in tumours of the ovary. Intl J Cancer 84: 101-108
25. Paley PJ, Staskus KA, Gebhard K, Mohanraj D, Twiggs LB and Carson LF et al (1997) Vascular endothelial growth factor expression in early stage ovarian carcinoma. Cancer 80: 98-106
26. Peterson F (1988) Annual Report on Gynecological Cancer of FIGO, Vol. 20. Panorama Press: Stockholm
27. Senger DR, Galli SJ, Dvorak AM, Perruzzi CA, Harvey VS and Dvorak HS (1983) Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 219: 983-985
28. Serov SF, Scully RE and Sobin LH (1973) Histological typing of ovarian tumours. International Histological Classification of Tumors, No 9. World Health Organization: Geneva
29. Sowter HM, Corps AN, Evans AL, Clark DE, Charnock-Jones DS, Smith SK (1997) Expression and localization of the vascular endothelial growth factor family in ovarian epithelial tumours. Lab Invest 77: 607-614
30. Tempfer C, Obermair A, Hefler L, Haeusler G, Gitsch G and Kainz C (1998) Vascular endothelial growth factor serum concentrations in ovarian cancer. Obstet Gynecol 92: 360-363
31. Terman BI, Dougher-Vermazen M, Carrion ME, Dimitrov D, Armellino DC, Gospodarwics D and Bohlen P (1992) Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor. Science 255: 989-991
32. Tischer E, Mitchell R, Hartman T, Silva M, Gospodarowicz D, Fiddes JC, Abraham JA (1991) The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative axon splicing. J Biol Chem 266: 26031-26037
33. Weidner N, Semple JP, Welch WR and Folkman J (1991) Tumour angiogenesis and metastasis: correlation in invasive breast carcinoma. N Engl J Med 324: 1-8
34. Weidner N and Folkman J (1996) Tumour vascularity as a prognostic factors in cancer. In: Important Advances in Oncology, VT De Vita VT, Hellman S and SA Rosenberg SA. (eds), pp. 167-190. Lippincott-Raven: Philadelphia
35. Yamamoto S, Konishi I, Mandai M, Kuroda H, Komatsu T and Nanbu K, et al. (1997) Expression of vascular growth factor (VEGF) in epithelial ovarian neoplasms: Correlation with clinicopathology and patient survival, and analysis of serum VEGF levels. Br J Cancer 76: 1221-1227